AuriGen Medical
Financials
Estimates*
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
€2.5m | Grant | ||
€3.0m | Grant | ||
€5.7m | Grant | ||
N/A | €2.1m | Seed | |
€500k | Seed | ||
€2.5m | Grant | ||
N/A | Early VC | ||
€1.0m | Seed | ||
* | €1.5m | Early VC | |
€1.0m | Early VC | ||
Total Funding | CAD29.6m |
Related Content
Recent News about AuriGen Medical
EditManufacturer of minimally invasive devices intended to treat patients suffering from complex chronic cardiac disease. The company's devices are built around custom left atrial appendage (LAA) occluder implants, to which synergistic modules like cardiac monitoring, ablation, or both modules can be added, offering cost-benefit treatment without the need for anti-coagulants and anti-arrhythmic medicines resulting in significant improvements in patient outcomes.
Keywords: Healthcare Devices, Services, Supplies, Arrhythmia Therapy, Atrial Fibrillation Treatment, Heart Care, Heart Failure, Implants Technology, Medical Devices, Medical Technology Company, Remote Monitoring, Remote Monitoring Technology, Stroke Therapeutics, Telemedicine.